pharmaphorum

DECEMBER 15, 2022

Currently, the only treatment option for people with IPF fibrosis who have an FVC above 80% predicted is supportive care, so the new guidance takes Ofev into new territory for pharmacological treatment of the progressive lung disease, characterised by damage and scarring to the tissue surrounding the small airways in the lungs.

Pharmacology 101

Pharmacology Doctors Patients Medicine 101

pharmaphorum

NOVEMBER 1, 2022

Date: 8 – 9 February 2023. In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. Director, Clinical Pharmacology. 14th Annual RNA Therapeutics. Location: London, UK. Website: [link].

Pharmacology 52

Pharmacology Medicine Networking Pharma 52

European Pharmaceutical Review

APRIL 13, 2023

Psychedelic research: evaluating the fast-evolving regulatory roadmap Psychedelics: the position in Europe The EMA’s recent letter confirms that as of 17 February 2023 in the EU, 6 there were: 11 ongoing clinical trials in EU with psilocybin for a range of central nervous system conditions four ongoing trials with MDMA one trial with LSD.

Medicine 114

Medicine Food and Drug Administration Doctors Government 114

pharmaphorum

OCTOBER 26, 2022

mjn-SERAS already has a CE mark in Europe and is currently in clinical testing, with results due in 2023. The platform has been developed with support from the EU’s European Institute of Technology Health (EIT Health) and funding from the Horizon 2020 programme, along with industrial and academic partners.

Pharmacology 62

Pharmacology Patients Sales Healthcare 62

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks. It was first launched in the US in 2008.

Pharmacology 52

Pharmacology FDA Pharma Marketing 52

pharmaphorum

DECEMBER 22, 2022

Regulators in the US and EU have started a review of Pfizer’s S1P receptor modulator etrasimod for people living with moderately-to-severely active ulcerative colitis (UC), with decisions expected in the first halves of 2023 and 2024, respectively.

Pharmacology 52

Pharmacology Safety Patients Marketing 52

European Pharmaceutical Review

MAY 2, 2023

He received an MD from the Georg August University of Göttingen and completed a postdoctoral Master’s in Medical Sciences Clinical Pharmacology at the University of Glasgow. cited 2023 Apr 4]. 2019 [cited 2023 Apr 4]. cited 2023 Apr 4]. cited 2023 Apr 4]. cited 2023 Apr 4]. 2023 [cited 2023 Apr 4].

Patients 99

Patients Medicine Marketing Medical 99

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. Internet] 2023. References 1. World Health Organization.

Medicine 90

Medicine Pharmacology Healthcare Healthcare 90

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 85

FDA Healthcare Healthcare Medicine 85

Legacy MEDSearch

OCTOBER 13, 2022

market launch planned for early 2023. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy , an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 90,000 patients globally. this quarter, with a broad U.S.

FDA 52

FDA Food and Drug Administration Recruitment Pharmacology 52

European Pharmaceutical Review

FEBRUARY 14, 2024

Firstly, the pharmacological response to LBPs does not follow traditional pharmacokinetic principles. 2023; 28(2):860 The post Navigating the unique CMC challenges of oral anaerobic live biotherapeutics appeared first on European Pharmaceutical Review. Gullifa G, Risoluti R, Mazzoni C, et al.

Food and Drug Administration 77

Food and Drug Administration Manufacturing Engineering Pharmacology 77

European Pharmaceutical Review

MARCH 6, 2024

The facility will also have capacity to conduct non-clinical pharmacology studies for detailed characterisation of its first-in-class development candidates, according to Ariceum. Internet] European Pharmaceutical Review, Issue 3 2023. 1 References Jaafar-Thiel. Meeting rising demands of a new radiotheranostic era. cited 2024Mar].

Pharmacology 88

Pharmacology Leads Pharmaceutical Patients 88

European Pharmaceutical Review

OCTOBER 27, 2022

Ahead of the world’s largest pharma event, CPHI Frankfurt – hosted at the Frankfurt Messe (1-3 November, 2022) – part i of the CPHI Annual Report looks ahead at the opportunities for biologics outsourcing and contract manufacturing organisastions (CMOs) in 2023. In the report some 50.4 percent in 2021).

Biopharma 81

Biopharma Manufacturing Pharmacology Training 81

Pharmaceutical Technology

MARCH 17, 2023

Companies are testing the use of digital platforms along with pharmacological treatments. But while appealing, the prospects of developing a merged approach that combines both digital and pharmacological therapeutics remain challenging.

Prescription 111

Prescription Pharmacology Pharma Medical 111

European Pharmaceutical Review

JANUARY 18, 2024

billion by 2023, driven by the launch of Merck’s Belsomra and Eisai’s lemborexant (E-2006). GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. billion across the 7MM up to 2032, GlobalData’s predicted in a report published in December 2023.

Marketing 90

Marketing Sales Pharmacology Pharma 90

Rep-Lite

JUNE 28, 2023

According to recent statistics, the global medical technology market is projected to reach a staggering US$570.70bn in 2023. Look for programs that offer courses in sales and marketing, healthcare management, biology, pharmacology, or medical technology.

Medical sales 52

Medical sales Medical Sales Medical sales reps 52

European Pharmaceutical Review

DECEMBER 11, 2023

Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. Bennett CF, Krainer AR, Cleveland DW. 2019 ;42:385-406. JCI Insight.

Pharmacology 83

Pharmacology Safety Engineering Medical 83

Pharmaceutical Technology

DECEMBER 16, 2022

This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology.

Pharmacology 105

Pharmacology Pharma Pharmaceutical Manufacturing 105

Pharmaceutical Technology

NOVEMBER 3, 2022

The Australian Department of Health and Aged Care published a similar statement on August 25, stating that tenecteplase shortages will likely affect the country until the end of 2023. But these substitutions do not come without complications, as these drugs can vary in their pharmacologic properties, states Page.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

European Pharmaceutical Review

SEPTEMBER 22, 2023

Prior to joining Novimmune in 2002, she was Head of Immunology and Preclinical Pharmacology at the Serono Pharmaceutical Research Institute, a Senior Scientist and then Head of Immunology at the Glaxo Wellcome Research Institute in Geneva, and a Scientific Member of the Basel Institute for Immunology. 2023 AD/PD Conference.

Food and Drug Administration 77

Food and Drug Administration Safety Patients Leads 77

Pharmaceutical Technology

OCTOBER 10, 2022

The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). The company plans to submit a request for advice from the FDA at the end of this year or the start of 2023, he adds.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

JUNE 15, 2023

Combined with pharmacologic and biologic insight, Confo Therapeutics’ platform allows the company to develop a multi-indication drug candidates pipeline with the aim of transforming therapeutic outcomes for patients living with severe illnesses.

Pharmacology 52

Pharmacology Medicine Sales Leads 52